Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lee YH"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 23
Tytuł:
Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.
Autorzy:
Choi HS; Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.; Institute of Health Science, Gyeongsang National University, Jinju, Republic of Korea.
Kang KM; Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.; Institute of Health Science, Gyeongsang National University, Jinju, Republic of Korea.
Jeong BK; Institute of Health Science, Gyeongsang National University, Jinju, Republic of Korea.; Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea.
Jeong H; Institute of Health Science, Gyeongsang National University, Jinju, Republic of Korea.; Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea.
Lee YH; Department of Radiation Oncology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
Ha IB; Institute of Health Science, Gyeongsang National University, Jinju, Republic of Korea.; Department of Radiation Oncology, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, Republic of Korea.
Song JH; Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Jun; Vol. 17 (3), pp. 209-215. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*mortality
Chemoembolization, Therapeutic/*mortality
End Stage Liver Disease/*mortality
Liver Neoplasms/*mortality
Portal Vein/*pathology
Radiosurgery/*mortality
Venous Thrombosis/*mortality
Adult ; Aged ; Carcinoma, Hepatocellular/complications ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/therapy ; Combined Modality Therapy ; End Stage Liver Disease/complications ; End Stage Liver Disease/pathology ; End Stage Liver Disease/therapy ; Female ; Humans ; Liver Neoplasms/complications ; Liver Neoplasms/pathology ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; Venous Thrombosis/complications ; Venous Thrombosis/pathology ; Venous Thrombosis/therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sinularin, an Anti-Cancer Agent Causing Mitochondria-Modulated Apoptosis and Cytoskeleton Disruption in Human Hepatocellular Carcinoma.
Autorzy:
Ko CY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan.; Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Shih PC; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.; UCL School of Pharmacy, University College London, Bloomsbury, London WC1N 1AX, UK.
Huang PW; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Lee YH; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Chen YF; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan.
Tai MH; Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.; Center for Neuroscience, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Liu CH; Division of Nephrology, Department of Interanl Medicine, Kashsiung Armed Forces General Hospital, Kaohsiung 80284, Taiwan.
Wen ZH; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Kuo HM; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.; Center for Neuroscience, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 11; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 11.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular*/drug therapy
Carcinoma, Hepatocellular*/metabolism
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/drug therapy
Liver Neoplasms*/metabolism
Liver Neoplasms*/pathology
Antineoplastic Agents/*pharmacology
Apoptosis/*drug effects
Cytoskeleton/*metabolism
Diterpenes/*pharmacology
Heterocyclic Compounds, 3-Ring/*pharmacology
Mitochondria, Liver/*metabolism
Animals ; Cell Line, Tumor ; Cytoskeleton/pathology ; Humans ; MAP Kinase Signaling System/drug effects ; Mitochondria, Liver/pathology ; Rats
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation.
Autorzy:
Lee SR; College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134, South Korea.
Kwon SW; College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134, South Korea.
Lee YH; College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134, South Korea.
Kaya P; College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134, South Korea.
Kim JM; Translational Xenotransplantation Research Center, Seoul National University, Seoul, Republic of Korea.
Ahn C; College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.
Jung EM; College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.
Lee GS; Kangwon National University, Chuncheon, Gangwon, Republic of Korea.
An BS; Department of Biomaterials Science, College of Natural Resources & Life Science, Pusan National University, Miryang, Republic of Korea.
Jeung EB; College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea.
Park BK; College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134, South Korea.
Hong EJ; College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Suite 401Veterinary medicine Bldg., Yuseong, Daejeon, 34134, South Korea. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Jan 03; Vol. 19 (1), pp. 6. Date of Electronic Publication: 2019 Jan 03.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*diet therapy
Genistein/*administration & dosage
Liver Neoplasms/*diet therapy
Protein Kinases/*genetics
AMP-Activated Protein Kinase Kinases ; Animals ; Apoptosis/drug effects ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Liver/drug effects ; Liver/pathology ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Male ; Mice ; RAW 264.7 Cells
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effect of exposure to Asian sand dust-Particulate matter on liver Tenascin-C expression in human cancer cell and mouse hepatic tissue.
Autorzy:
Lee YH; Department of Health Sciences and Technology, GAIHST, Gachon University, Korea.
Kim DY; Department of Life Science, College of BIONANO, Gachon University, Korea.
Jeong SH; Department of Internal Medicine, Gil hospital, College of Medicine, Gachon University, Korea.
Hwang YJ; Department of Health Sciences and Technology, GAIHST, Gachon University, Korea.; Department of Bio-Medical Engineering, College of Health Science, Gachon University, Korea.
Pokaż więcej
Źródło:
The Journal of toxicological sciences [J Toxicol Sci] 2019; Vol. 44 (9), pp. 633-641.
Typ publikacji:
Journal Article
MeSH Terms:
Dust*
Sand*
Carcinoma, Hepatocellular/*metabolism
Environmental Exposure/*adverse effects
Liver/*metabolism
Liver Neoplasms/*metabolism
Particulate Matter/*toxicity
Tenascin/*metabolism
Aerosols ; Animals ; Cell Line, Tumor ; China ; Fibronectins/genetics ; Fibronectins/metabolism ; Gene Expression ; Humans ; Liver/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mongolia ; Particulate Matter/metabolism ; Tenascin/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma.
Autorzy:
Ho SY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Liu PH; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Hsu CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA.
Hsia CY; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Su CW; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
He YJ; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huang YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Hou MC; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huo TI; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. .; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. .; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2018 Oct 10; Vol. 8 (1), pp. 15074. Date of Electronic Publication: 2018 Oct 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular/*complications
Carcinoma, Hepatocellular/*pathology
Liver Cirrhosis/*complications
Liver Cirrhosis/*diagnosis
Liver Neoplasms/*complications
Liver Neoplasms/*pathology
Aged ; Biomarkers ; Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/therapy ; Female ; Humans ; Liver Cirrhosis/etiology ; Liver Neoplasms/etiology ; Liver Neoplasms/therapy ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Staging ; Prognosis ; Reproducibility of Results ; Risk Factors ; Severity of Illness Index ; Tomography, X-Ray Computed ; Tumor Burden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system.
Autorzy:
Hsu CY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Nevada School of Medicine, Reno, NV, USA.
Liu PH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Ho SY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huang YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee RC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Nagaria TS; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Hou MC; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huo TI; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2018 Oct; Vol. 38 (10), pp. 1803-1811. Date of Electronic Publication: 2018 Apr 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Severity of Illness Index*
Carcinoma, Hepatocellular/*mortality
Liver Neoplasms/*mortality
Aged ; Carcinoma, Hepatocellular/pathology ; Female ; Humans ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Risk Factors ; Survival Analysis ; Taiwan/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.
Autorzy:
Hsu CY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Nevada School of Medicine, Reno, NV, USA.
Liu PH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Ho SY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Hsia CY; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Kudaravalli P; Department of Internal Medicine, University of Nevada School of Medicine, Reno, NV, USA.
Lee YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Chiou YY; Departments of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Tsai YJ; Renown Regional Medical Center, Reno, NV, USA.
Huang YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huo TI; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. .; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. .; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan. .; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2018 Mar 14; Vol. 18 (1), pp. 289. Date of Electronic Publication: 2018 Mar 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Decision Support Techniques*
Nomograms*
Patient Selection*
Carcinoma, Hepatocellular/*diagnosis
Liver Neoplasms/*diagnosis
Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/therapy ; Catheter Ablation ; Chemoembolization, Therapeutic ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Neoplasm Staging ; Propensity Score ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.
Autorzy:
Hsu CY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Nevada School of Medicine, Reno, NV, United States of America.
Liu PH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Harvard T.H. Chan School of Public Health, Boston, MA, United States of America.
Ho SY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huang YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Chiou YY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsieh TH; Gastroenterology Consultants, Reno, NV, United States of America.
Fang T; Gastroenterology Consultants, Reno, NV, United States of America.
Tsai YJ; Renown Regional Medical Center, Reno, NV, United States of America.
Hou MC; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huo TI; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Nov 10; Vol. 12 (11), pp. e0188031. Date of Electronic Publication: 2017 Nov 10 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Autorzy:
Ho SY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Liu PH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Hsu CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Nevada School of Medicine, Reno, Nevada, United States of America.
Hsia CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee RC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Huang YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee FY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Hou MC; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Tsai YJ; Renown Regional Medical Center, Reno, Nevada, United States of America.
Huo TI; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Jul 03; Vol. 12 (7), pp. e0180408. Date of Electronic Publication: 2017 Jul 03 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Chemoembolization, Therapeutic*
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*pathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.
Autorzy:
Su YW; Departments of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Liu PH; Departments of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Hsu CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Nevada School of Medicine, Reno, Nevada, United States of America.
Lee YH; Departments of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Hsia CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Departments of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Ho SY; Departments of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hou MC; Departments of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Chen HS; Departments of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huo TI; Departments of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2017 Mar 23; Vol. 12 (3), pp. e0174333. Date of Electronic Publication: 2017 Mar 23 (Print Publication: 2017).
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*complications
Diabetes Mellitus, Type 1/*complications
Liver Neoplasms/*complications
Aged ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Diabetes Mellitus, Type 1/diagnosis ; Diabetes Mellitus, Type 1/mortality ; Female ; Humans ; Liver Neoplasms/diagnosis ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Risk Factors ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Nomogram of the Barcelona Clinic Liver Cancer system for individual prognostic prediction in hepatocellular carcinoma.
Autorzy:
Hsu CY; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Nevada School of Medicine, Reno, NV, USA.
Liu PH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Hsia CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Al Juboori A; Department of Internal Medicine, University of Nevada School of Medicine, Reno, NV, USA.
Lee RC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Lin HC; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huo TI; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. .; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. .; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan. .
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2016 Oct; Vol. 36 (10), pp. 1498-506. Date of Electronic Publication: 2016 Apr 04.
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
Carcinoma, Hepatocellular/*mortality
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*mortality
Liver Neoplasms/*pathology
Neoplasm Staging/*methods
Aged ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Nomograms ; Proportional Hazards Models ; Retrospective Studies ; Survival Rate ; Taiwan/epidemiology ; Tumor Burden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Electro-hyperthermia up-regulates tumour suppressor Septin 4 to induce apoptotic cell death in hepatocellular carcinoma.
Autorzy:
Jeon TW; a Department of Radiation Oncology , Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;; d Department of Molecular Medicine , Keimyung University School of Medicine , Daegu , Republic of Korea.
Yang H; a Department of Radiation Oncology , Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;
Lee CG; a Department of Radiation Oncology , Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;
Oh ST; a Department of Radiation Oncology , Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;
Seo D; b Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;
Baik IH; a Department of Radiation Oncology , Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;; d Department of Molecular Medicine , Keimyung University School of Medicine , Daegu , Republic of Korea.
Lee EH; a Department of Radiation Oncology , Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;
Yun I; a Department of Radiation Oncology , Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine , Seoul ;
Park KR; c Department of Radiation Oncology , Ewha Women's University Medical Center , Seoul , Republic of Korea ;
Lee YH; d Department of Molecular Medicine , Keimyung University School of Medicine , Daegu , Republic of Korea.
Pokaż więcej
Źródło:
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2016 Sep; Vol. 32 (6), pp. 648-56. Date of Electronic Publication: 2016 Jun 07.
Typ publikacji:
Journal Article
MeSH Terms:
Hyperthermia, Induced*
Carcinoma, Hepatocellular/*metabolism
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*metabolism
Liver Neoplasms/*therapy
Septins/*metabolism
Animals ; Apoptosis ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Cell Proliferation ; Humans ; Liver Neoplasms/pathology ; Mice, Nude ; Tumor Burden ; Up-Regulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
DDX3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.
Autorzy:
Li HK; Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.
Mai RT; Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
Huang HD; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.; Institute of Bioinformatics and Systems Biology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
Chou CH; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.; Institute of Bioinformatics and Systems Biology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
Chang YA; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.; Department of Medical Research, Mackay Memorial Hospital, Hsinchu, Taiwan.
Chang YW; Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.
You LR; Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.
Chen CM; Department of Life Sciences and Institute of Genome Sciences, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.
Lee YH; Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan.; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Jun 27; Vol. 6, pp. 28637. Date of Electronic Publication: 2016 Jun 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epigenesis, Genetic*
Gene Expression Regulation, Enzymologic*
Gene Expression Regulation, Neoplastic*
Carcinoma, Hepatocellular/*enzymology
DEAD-box RNA Helicases/*biosynthesis
Liver Neoplasms/*enzymology
Neoplasm Proteins/*biosynthesis
Neoplastic Stem Cells/*enzymology
Animals ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; DEAD-box RNA Helicases/genetics ; DNA Methyltransferase 3A ; Hep G2 Cells ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Male ; Mice ; Mice, Nude ; Mice, SCID ; Neoplasm Proteins/genetics ; Neoplastic Stem Cells/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Solitary Large Hepatocellular Carcinoma: Staging and Treatment Strategy.
Autorzy:
Liu PH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Su CW; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Hsu CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Internal Medicine, University of Nevada School of Medicine, Reno, Nevada, United States of America.
Hsia CY; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huang YH; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lee RC; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Lin HC; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Huo TI; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 May 13; Vol. 11 (5), pp. e0155588. Date of Electronic Publication: 2016 May 13 (Print Publication: 2016).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular/*pathology
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*pathology
Liver Neoplasms/*therapy
Aged ; Carcinoma, Hepatocellular/surgery ; Chemoembolization, Therapeutic ; Female ; Hepatectomy ; Humans ; Liver Neoplasms/surgery ; Male ; Middle Aged ; Models, Biological ; Multivariate Analysis ; Neoplasm Staging ; Prognosis ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma.
Autorzy:
Nie W; Chongqing University Innovative Drug Research Centre, School of Chemistry and Chemical Engineering, Chongqing, 401331, PR China.
Yan L; Chongqing University Innovative Drug Research Centre, School of Chemistry and Chemical Engineering, Chongqing, 401331, PR China.
Lee YH; Interdisciplinary Research Group in Infectious Diseases, Singapore-MIT Alliance for Research & Technology, Singapore, 138602, Singapore.
Guha C; Department of Radiation Oncology, Montefiore Medical Center, New York, New York, 10461.; Department of Medicine, Albert Einstein College of Medicine, New York, New York, 10461.
Kurland IJ; Stable Isotope and Metabolomics Core Facility, Diabetes Research and Training Center, Department of Medicine, Albert Einstein College of Medicine, New York, New York, 10461.
Lu H; Chongqing University Innovative Drug Research Centre, School of Chemistry and Chemical Engineering, Chongqing, 401331, PR China.; Tissue Repair and Regeneration Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, QLD, 4059, Australia.
Pokaż więcej
Źródło:
Mass spectrometry reviews [Mass Spectrom Rev] 2016 May-Jun; Vol. 35 (3), pp. 331-49. Date of Electronic Publication: 2014 Jun 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*pathology
Mass Spectrometry/*methods
Metabolomics/*methods
Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; DNA Adducts/analysis ; DNA Adducts/metabolism ; DNA Damage ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Proteomics/methods ; RNA/chemistry ; RNA/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma.
Autorzy:
Farinati F; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Vitale A; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Spolverato G; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Pawlik TM; Department of Surgery, Johns Hopkins Hospital, Baltimore, Maryland, United States of America.
Huo TL; National Yang-Ming University, Taipei City, Taiwan.; Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
Lee YH; National Yang-Ming University, Taipei City, Taiwan.; Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan.
Frigo AC; Biostatistics Unit, University of Padua, Padua, Italy.
Giacomin A; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Giannini EG; Gastroenterology Unit, Department of Internal Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino IST, University of Genoa, Genoa, Italy.
Ciccarese F; Division of Surgery, San Marco Hospital, Zingonia, Italy.
Piscaglia F; Division of Internal Medicine, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Rapaccini GL; Division of Internal Medicine and Gastroenterology, Complesso Integrato Columbus, Università Cattolica del Sacro Cuore, Rome, Italy.
Di Marco M; Division of Medicine, Bolognini Hospital, Seriate, Italy.
Caturelli E; Division of Gastroenterology, Belcolle Hospital, Viterbo, Italy.
Zoli M; Division of Internal Medicine, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Borzio F; Division of Radiology, Department of Medicine, Fatebenefratelli Hospital, Milan, Italy.
Cabibbo G; Division of Gastroenterology, Biomedical Department of Internal and Specialistic Medicine, University of Palermo, Palermo, Italy.
Felder M; Division of Gastroenterology, Bolzano Regional Hospital, Bolzano, Italy.
Sacco R; Division of Gastroenterology and Metabolic Diseases, University Hospital of Pisa, Pisa, Italy.
Morisco F; Division of Gastroenterology, Department of Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Biasini E; Division of Infectious Diseases and Hepatology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Foschi FG; Department of Internal Medicine, Ospedale per gli Infermi di Faenza, Faenza, Italy.
Gasbarrini A; Division of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy.
Svegliati Baroni G; Division of Gastroenterology, Polytechnic University of Marche, Ancona, Italy.
Virdone R; Division of Internal Medicine 2, Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.
Masotto A; Gastroenterology Unit, Ospedale Sacro Cuore Don Calabria, Negrar, Italy.
Trevisani F; Division of Semeiotics, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Cillo U; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Pokaż więcej
Corporate Authors:
ITA.LI.CA study group
Źródło:
PLoS medicine [PLoS Med] 2016 Apr 26; Vol. 13 (4), pp. e1002006. Date of Electronic Publication: 2016 Apr 26 (Print Publication: 2016).
Typ publikacji:
Journal Article; Multicenter Study; Validation Study
MeSH Terms:
Carcinoma, Hepatocellular/*blood
Carcinoma, Hepatocellular/*secondary
Liver Neoplasms/*blood
Liver Neoplasms/*pathology
Neoplasm Staging/*methods
alpha-Fetoproteins/*analysis
Aged ; Carcinoma, Hepatocellular/mortality ; Databases, Factual ; Decision Support Techniques ; Female ; Humans ; Italy ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasms, Multiple Primary ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Survival Analysis ; Taiwan ; Time Factors ; Tumor Burden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?
Autorzy:
Hsu CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Biostatistics, University of California Los Angeles, Los Angeles, California, United States of America.
Liu PH; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee YH; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsia CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Huang YH; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Lin HC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chiou YY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee FY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Huo TI; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Mar 04; Vol. 10 (3), pp. e0118825. Date of Electronic Publication: 2015 Mar 04 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blood Chemical Analysis/*standards
Carcinoma, Hepatocellular/*blood
Carcinoma, Hepatocellular/*diagnosis
Liver Neoplasms/*blood
Liver Neoplasms/*diagnosis
alpha-Fetoproteins/*metabolism
Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Propensity Score ; Reference Standards ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systems.
Autorzy:
Lee YH; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Yuanshan Branch of Taipei Veterans General Hospital, Taipei, Taiwan.
Hsu CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Biostatistics, University of California Los Angeles, Los Angeles, California, United States of America.
Chu CW; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Yuanshan Branch of Taipei Veterans General Hospital, Taipei, Taiwan.
Liu PH; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsia CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Huang YH; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Su CW; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chiou YY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Lin HC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Huo TI; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Jun 06; Vol. 9 (6), pp. e99115. Date of Electronic Publication: 2014 Jun 06 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/mortality
Carcinoma, Hepatocellular*/pathology
Carcinoma, Hepatocellular*/therapy
Liver Neoplasms*/blood
Liver Neoplasms*/diagnosis
Liver Neoplasms*/mortality
Liver Neoplasms*/pathology
Liver Neoplasms*/therapy
Disease-Free Survival ; Female ; Humans ; Male ; Neoplasm Staging ; Predictive Value of Tests ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.
Autorzy:
Hsu CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan ; Department of Biostatistics, UCLA, Los Angeles, California, United States of America.
Lee YH; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Liu PH; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsia CY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.
Huang YH; Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Lin HC; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chiou YY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Radiology, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee FY; Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Huo TI; Institute of Pharmacology, National Yang-Ming University School of Medicine, Taipei, Taiwan ; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 Feb 24; Vol. 9 (2), pp. e89373. Date of Electronic Publication: 2014 Feb 24 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Hepatocellular/*mortality
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*mortality
Liver Neoplasms/*pathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Propensity Score ; Proportional Hazards Models ; Prospective Studies ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A prognostic model for patients with hepatocellular carcinoma within the Milan criteria undergoing non-transplant therapies, based on 1106 patients.
Autorzy:
Lee YH; Faculty of Medicine, National Yang- Ming University School of Medicine, Taipei, Taiwan.
Hsu CY
Hsia CY
Huang YH
Su CW
Lin HC
Chiou YY
Huo TI
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2012 Sep; Vol. 36 (6), pp. 551-9. Date of Electronic Publication: 2012 Jul 22.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*diagnosis
Carcinoma, Hepatocellular/*therapy
Liver Neoplasms/*diagnosis
Liver Neoplasms/*therapy
Aged ; Ascites/blood ; Bilirubin/blood ; Carcinoma, Hepatocellular/blood ; Decision Support Techniques ; Female ; Humans ; Liver Neoplasms/blood ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Random Allocation ; Retrospective Studies ; Risk Factors ; Severity of Illness Index ; Taiwan ; alpha-Fetoproteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 23

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies